Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +17.56%
#2 Fake World Assets Fake World Assets +13.79%
#3 B3 (Base) B3 (Base) +10.99%
#4 OriginTrail OriginTrail +6.62%
#5 Pons Pons +6.30%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +4.89%
#7 Siren Siren +4.48%
#8 Ontology Gas Ontology Gas +4.02%
#9 Storj Storj +3.91%
#10 Geodnet Geodnet +3.30%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
設定
言語
日本
通貨
USD
テーマ
Formosa Pharmaceuticals, Inc. Formosa Pharmaceuticals, Inc.

Formosa Pharmaceuticals, Inc.

6838
株式のランク #20880
Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei... Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei City, Taiwan, is actively engaged in both late-preclinical and early clinical development stages. Its core focus lies in pioneering therapeutic candidates across ophthalmology, oncology, and anti-infective domains. Among its key investigational assets is APP13007, an ophthalmic nanosuspension, currently progressing through Phase III trials for managing post-surgical discomfort and inflammation of the eye. The company's portfolio also encompasses TSY-0110, designed as an antibody-drug conjugate, and TSY-0210, an antibiotic targeting resilient drug-resistant infections. Further compounds under development include APP13002, a topical antibiotic intended for ocular infections like blepharitis, and MPT0E028, a novel pan-histone deacetylase inhibitor being explored for solid malignancies such as hepatomas and colorectal cancer, in addition to lung fibrosis. Additionally, Formosa Pharmaceuticals maintains a collaborative partnership with Eyenovia, Inc., dedicated to advancing innovative ophthalmic treatments. Established in 2010, the company is headquartered in Taiwan's capital.
株価
$0.79338575
最終同期: 2026-07-28
時価総額
$119.78M
変化（1日）
2.67%
変化（1年）
-27.61%
国
TW
取引 Formosa Pharmaceuticals, Inc. (6838)

カテゴリー

Healthcare
Formosa Pharmaceuticals, Inc.（6838）の株価履歴
終値の最高値: $0.76 （2026-07-01）

終値の最安値: $1.16 （2021-10-01）
Formosa Pharmaceuticals, Inc. の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 1.64%
2025 -27.82%
2024 -24.76%
2023 -6.74%
2022 43.68%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.69 -14.89%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH